NeuroBo Pharmaceuticals Total Liabilities 1970-1969 | MTVA
NeuroBo Pharmaceuticals total liabilities from 1970 to 1969. Total liabilities can be defined as the total value of all possible claims against the corporation.
NeuroBo Pharmaceuticals Annual Total Liabilities (Millions of US $) |
NeuroBo Pharmaceuticals Quarterly Total Liabilities (Millions of US $) |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|